5NQE
Human PARP14 (ARTD8), catalytic fragment in complex with an N-aryl piperazine inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I03 |
Synchrotron site | Diamond |
Beamline | I03 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2017-03-05 |
Detector | DECTRIS PILATUS3 6M |
Wavelength(s) | 0.97625 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 83.430, 90.360, 80.070 |
Unit cell angles | 90.00, 116.42, 90.00 |
Refinement procedure
Resolution | 45.180 - 2.710 |
R-factor | 0.228 |
Rwork | 0.227 |
R-free | 0.25800 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4f1l |
RMSD bond length | 0.010 |
RMSD bond angle | 1.120 |
Data reduction software | xia2 |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | BUSTER (2.10.3) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 45.200 | 2.870 |
High resolution limit [Å] | 2.710 | 2.710 |
Rmerge | 0.288 | 1.153 |
Number of reflections | 14476 | 14938 |
<I/σ(I)> | 6.5 | 1.7 |
Completeness [%] | 99.0 | 97.5 |
Redundancy | 6.7 | 6.5 |
CC(1/2) | 0.984 | 0.641 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 277 | 20% PEG3350, 0.2M Sodium-malonate |